These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

408 related articles for article (PubMed ID: 15673768)

  • 1. Rapid acquisition of stable azole resistance by Candida glabrata isolates obtained before the clinical introduction of fluconazole.
    Borst A; Raimer MT; Warnock DW; Morrison CJ; Arthington-Skaggs BA
    Antimicrob Agents Chemother; 2005 Feb; 49(2):783-7. PubMed ID: 15673768
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanisms of azole resistance in clinical isolates of Candida glabrata collected during a hospital survey of antifungal resistance.
    Sanguinetti M; Posteraro B; Fiori B; Ranno S; Torelli R; Fadda G
    Antimicrob Agents Chemother; 2005 Feb; 49(2):668-79. PubMed ID: 15673750
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression Patterns of ABC Transporter Genes in Fluconazole-Resistant Candida glabrata.
    Gohar AA; Badali H; Shokohi T; Nabili M; Amirrajab N; Moazeni M
    Mycopathologia; 2017 Apr; 182(3-4):273-284. PubMed ID: 27744635
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The ATP binding cassette transporter gene CgCDR1 from Candida glabrata is involved in the resistance of clinical isolates to azole antifungal agents.
    Sanglard D; Ischer F; Calabrese D; Majcherczyk PA; Bille J
    Antimicrob Agents Chemother; 1999 Nov; 43(11):2753-65. PubMed ID: 10543759
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activity of Isavuconazole and Other Azoles against Candida Clinical Isolates and Yeast Model Systems with Known Azole Resistance Mechanisms.
    Sanglard D; Coste AT
    Antimicrob Agents Chemother; 2016 Jan; 60(1):229-38. PubMed ID: 26482310
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of ATP-binding-cassette transporter genes in high-frequency acquisition of resistance to azole antifungals in Candida glabrata.
    Sanglard D; Ischer F; Bille J
    Antimicrob Agents Chemother; 2001 Apr; 45(4):1174-83. PubMed ID: 11257032
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The ATP-binding cassette transporter-encoding gene CgSNQ2 is contributing to the CgPDR1-dependent azole resistance of Candida glabrata.
    Torelli R; Posteraro B; Ferrari S; La Sorda M; Fadda G; Sanglard D; Sanguinetti M
    Mol Microbiol; 2008 Apr; 68(1):186-201. PubMed ID: 18312269
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Changes in karyotype and azole susceptibility of sequential bloodstream isolates from patients with Candida glabrata candidemia.
    Shin JH; Chae MJ; Song JW; Jung SI; Cho D; Kee SJ; Kim SH; Shin MG; Suh SP; Ryang DW
    J Clin Microbiol; 2007 Aug; 45(8):2385-91. PubMed ID: 17581937
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fungaemia caused by Candida glabrata with reduced susceptibility to fluconazole due to altered gene expression: risk factors, antifungal treatment and outcome.
    Tumbarello M; Sanguinetti M; Trecarichi EM; La Sorda M; Rossi M; de Carolis E; de Gaetano Donati K; Fadda G; Cauda R; Posteraro B
    J Antimicrob Chemother; 2008 Dec; 62(6):1379-85. PubMed ID: 18782778
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synergistic effects of tacrolimus and azole antifungal compounds in fluconazole-susceptible and fluconazole-resistant Candida glabrata isolates.
    Denardi LB; Mario DA; Loreto ÉS; Santurio JM; Alves SH
    Braz J Microbiol; 2015 Mar; 46(1):125-9. PubMed ID: 26221097
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mutations in the CgPDR1 and CgERG11 genes in azole-resistant Candida glabrata clinical isolates from Slovakia.
    Berila N; Borecka S; Dzugasova V; Bojnansky J; Subik J
    Int J Antimicrob Agents; 2009 Jun; 33(6):574-8. PubMed ID: 19196495
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Contribution of CgPDR1-regulated genes in enhanced virulence of azole-resistant Candida glabrata.
    Ferrari S; Sanguinetti M; Torelli R; Posteraro B; Sanglard D
    PLoS One; 2011 Mar; 6(3):e17589. PubMed ID: 21408004
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanisms of azole resistance among clinical isolates of Candida glabrata in Poland.
    Szweda P; Gucwa K; Romanowska E; Dzierz Anowska-Fangrat K; Naumiuk Ł; Brillowska-Da Browska A; Wojciechowska-Koszko I; Milewski S
    J Med Microbiol; 2015 Jun; 64(6):610-619. PubMed ID: 25818698
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Caspofungin activity against clinical isolates of azole cross-resistant Candida glabrata overexpressing efflux pump genes.
    Posteraro B; Sanguinetti M; Fiori B; La Sorda M; Spanu T; Sanglard D; Fadda G
    J Antimicrob Chemother; 2006 Aug; 58(2):458-61. PubMed ID: 16757500
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanisms of resistance to azole antifungal agents in Candida albicans isolates from AIDS patients involve specific multidrug transporters.
    Sanglard D; Kuchler K; Ischer F; Pagani JL; Monod M; Bille J
    Antimicrob Agents Chemother; 1995 Nov; 39(11):2378-86. PubMed ID: 8585712
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Missense mutation in CgPDR1 regulator associated with azole-resistant Candida glabrata recovered from Thai oral candidiasis patients.
    Tantivitayakul P; Lapirattanakul J; Kaypetch R; Muadcheingka T
    J Glob Antimicrob Resist; 2019 Jun; 17():221-226. PubMed ID: 30658200
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Milbemycins: more than efflux inhibitors for fungal pathogens.
    Silva LV; Sanguinetti M; Vandeputte P; Torelli R; Rochat B; Sanglard D
    Antimicrob Agents Chemother; 2013 Feb; 57(2):873-86. PubMed ID: 23208712
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular mechanisms associated with Fluconazole resistance in clinical Candida albicans isolates from India.
    Mane A; Vidhate P; Kusro C; Waman V; Saxena V; Kulkarni-Kale U; Risbud A
    Mycoses; 2016 Feb; 59(2):93-100. PubMed ID: 26648048
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Azole resistance of Candida glabrata in a case of recurrent fungemia.
    Posteraro B; Tumbarello M; La Sorda M; Spanu T; Trecarichi EM; De Bernardis F; Scoppettuolo G; Sanguinetti M; Fadda G
    J Clin Microbiol; 2006 Aug; 44(8):3046-7. PubMed ID: 16891541
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Microarray and molecular analyses of the azole resistance mechanism in Candida glabrata oropharyngeal isolates.
    Tsai HF; Sammons LR; Zhang X; Suffis SD; Su Q; Myers TG; Marr KA; Bennett JE
    Antimicrob Agents Chemother; 2010 Aug; 54(8):3308-17. PubMed ID: 20547810
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.